Dennis Chornenky

• Chief AI Advisor for UC Davis Health
• Former Senior Advisor and Strategy Consultant in Artificial Intelligence and Emerging Technology for the White House

Dennis Chornenky is an executive with 20 years of leadership in healthcare, technology, and national security, with a focus on AI policy, governance, and adoption. His experience spans across business and government, including senior roles at the White House, UnitedHealth Group, and Morgan Stanley. He is the CEO of Domelabs AI, an AI advisory and technology company, the Chief AI Advisor at UC Davis Health, and the Founding Director of VALID AI, a new collaborative of over 40 leading health systems from across the United States and internationally, focused on accelerating the responsible adoption of generative AI in healthcare.

As a Senior Advisor and Presidential Innovation Fellow at the White House Office of Science and Technology Policy, Dennis led initiatives on AI policy, telehealth, and national security across two administrations and helped author the Executive Order on the Use of Trustworthy AI. As Senior Vice President and Chief AI Officer at UnitedHealth Group’s Optum Health, he developed an AI governance structure and managed a portfolio of AI applications for clinical and business environments. Dennis has also served as an investment banker at Morgan Stanley and Lazard, as a startup CEO, and as an executive advisor to healthcare and technology organizations, federal agencies, and startups. Dennis has delivered dozens of AI products for large organizations and conducted pioneering research on digital therapeutic models, telehealth, and responsible AI at Harvard Medical School and the MIT Analytics Lab.

Dennis holds a Bachelor of Arts in Political Science from UC Berkeley, a Master of Business Administration from the University of Oxford, Saïd Business School, and a Master of Public Health from the Harvard T.H. Chan School of Public Health, where he was trained as an epidemiologist and clinical data scientist. He also holds a Master of Science in Management of Technology and Business Analytics from the MIT Sloan School of Management, where he was a Sloan Fellow in Global Leadership and Innovation.